Overview

Evidence-based Stimulation Trial With Human rFSH in Europe and Rest of World 2

Status:
Completed
Trial end date:
2017-01-03
Target enrollment:
Participant gender:
Summary
This trial investigates the immunogenicity of FE 999049 in repeated cycles.
Phase:
Phase 3
Details
Lead Sponsor:
Ferring Pharmaceuticals
Treatments:
Follicle Stimulating Hormone